Navigating eCOA Licensing And Localization In Clinical Trials

By Emily Potz, Director, Licensing & Localization, Suvoda

eCOA (electronic Clinical Outcomes Assessment) has played a vital role in clinical trials for nearly two decades. However, traditional eCOA tools continue to face persistent challenges in delivery, execution quality, and logistics. Among the most pressing issues are licensing and localization, which are frequently cited by sponsors as particularly difficult and time-consuming. As clinical trials increasingly span multiple countries and sites, the complexity only grows. A typical study may involve several questionnaires, and when you factor in licensing requirements and localization demands, it becomes clear how easily study teams can become overwhelmed.

Delve into the reasons why licensing and localization are so burdensome and practical solutions to help study teams navigate these challenges. Don’t let these hurdles derail your timelines— Streamline your eCOA processes and keep your trials on track.